Appendix Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Ovarian, Colorectal, or Appendiceal Cancer
Conditions:   Peritoneal Carcinomatosis;   Peritoneal Neoplasms;   Ovarian Cancer;   Ovarian Neoplasms;   Colorectal Cancer;   Colorectal Neoplasms;   Appendiceal Cancer;   Appendiceal Neoplasms Interventions:   Drug: Paclitaxel;   Drug: Nilotinib Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2022 Category: Research Source Type: clinical trials

Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer
Conditions:   Colorectal Cancer;   Appendiceal Cancer;   Peritoneal Carcinoma Interventions:   Drug: Oxaliplatin;   Drug: mFOLFIRI Sponsor:   University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2019 Category: Research Source Type: clinical trials